Andere Sprachen Q32 Bio Inc.

Aktien

A4ZZ0Z

US7469641051

QTTB

Markt geschlossen - Nasdaq Andere Börsenplätze 22:00:00 14.05.2024			% 5 Tage	% 1. Jan.
28,42 ^USD	+2,41 %		+4,52 %	+153,56 %

09.05.	Q32 Bio Inc. bietet ein Unternehmens-Update	CI
11.04.	Q32 BIO INC. : Oppenheimer gibt eine Kauf-Bewertung ab	ZM

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Q32 Bio: Q1 Earnings Snapshot	09.05.
Q32 Bio Inc. Provides Corporate Update	09.05.
Q32 Bio Reports First Quarter 2024 Financial Results and Provides Corporate Update	09.05.
Q32 Bio Appoints Lee Kalowski as President & Chief Financial Officer	03.04.
Q32 Bio Inc. Appoints Lee Kalowski as Chief Financial Officer	03.04.
Q32 Bio Inc.(NasdaqGM:QTTB) added to NASDAQ Composite Index	26.03.
Homology Medicines, Inc.(NasdaqGS:FIXX) dropped from NASDAQ Composite Index	25.03.
Q32 Bio Inc. announced that it has received $42 million in funding from a group of investors	25.03.
Q32 Bio Inc. completed the acquisition of Homology Medicines, Inc. from 5AM Venture Management, LLC, Arch Venture Fund VIII, L.P. and ARCH Venture Fund VIII Overage, L.P. managed by Arch Venture Partners, L.P., Pfizer Inc. and TLS Beta Pte. Ltd. in a reverse merger transaction.	25.03.
North American Morning Briefing : Markets on Hold -2-	20.03.
Homology Medicines Declares Distribution to Common Stockholders	18.03.
Homology Medicines, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	13.03.
HOMOLOGY MEDICINES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Homology Medicines, Inc. - FIXX	27.02.
Neurogene Names Julie Jordan as Chief Medical Officer	16.01.
Homology Medicines Receives NASDAQ Notification Regarding Minimum Bid Price Deficiency	03.01.
HOMOLOGY MEDICINES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Homology Medicines, Inc. - FIXX	18.11.
FIXX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Homology Medicines, Inc. Is Fair to Shareholders	16.11.
Q32 Bio and Homology Medicines Announce Merger Agreement	16.11.
Q32 Bio and Homology Medicines Announce Merger Agreement	16.11.
Q32 Bio Inc. announced that it expects to receive $42 million in funding from a group of investors	16.11.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Q32 Bio Inc.

Aktien

A4ZZ0Z

US7469641051

QTTB

Andere Sprachen

Filter